Search Results

Chromogranin A (CGA)-derived polypeptide (CGA 47-66 ) inhibits TNF-α-induced vascular endothelial hyper-permeability through SOC-related Ca 2+ signaling.

• Authors : Luo L; Department of Emergency, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China; Department of Emergency, The Third People's Hospital of Chengdu, The Second Affiliated Chengdu Clinical College of Chongqing Medical University, Chengdu, Sichuan 610031, PR China.

Subjects: Calcium Signaling/Calcium Signaling/Calcium Signaling/*drug effects ; Chromogranin A/Chromogranin A/Chromogranin A/*pharmacology ; Endothelial Cells/Endothelial Cells/Endothelial Cells/*drug effects

• Source: Peptides [Peptides] 2020 Sep; Vol. 131, pp. 170297. Date of Electronic Publication: 2020 May 05.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 8008690 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Pancreastatin inhibitor, PSTi8 ameliorates metabolic health by modulating AKT/GSK-3β and PKCλ/ζ/SREBP1c pathways in high fat diet induced insulin resistance in peri-/post-menopausal rats.

• Authors : Valicherla GR; Pharmaceutics & Pharmacokinetics Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, India.

Subjects: Insulin Resistance*; Chromogranin A/Chromogranin A/Chromogranin A/*antagonists & inhibitors ; Dietary Fats/Dietary Fats/Dietary Fats/*pharmacology

• Source: Peptides [Peptides] 2019 Oct; Vol. 120, pp. 170147. Date of Electronic Publication: 2019 Aug 29.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 8008690 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Alteration in chromogranin A, obestatin and total ghrelin levels of saliva and serum in epilepsy cases.

• Authors : Dag E; Department of Neurology, Elazig Research and Education Hospital, Elazig 23119, Turkey.; Aydin S

Subjects: Chromogranin A/Chromogranin A/Chromogranin A/*metabolism ; Epilepsy/Epilepsy/Epilepsy/*blood ; Epilepsy/Epilepsy/Epilepsy/*metabolism

• Source: Peptides [Peptides] 2010 May; Vol. 31 (5), pp. 932-7. Date of Electronic Publication: 2010 Feb 19.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 8008690 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Agricola

Record details

Catestatin in defense of oxidative-stress-induced apoptosis: A novel mechanism by activating the beta2 adrenergic receptor and PKB/Akt pathway in ischemic-reperfused myocardium.

• Authors : Chu SY; Department of Cardiology, Peking University First Hospital, 100034, Beijing, China.; Peng F

Subjects: Apoptosis/Apoptosis/Apoptosis/*drug effects ; Chromogranin A/Chromogranin A/Chromogranin A/*pharmacology ; Myocardial Reperfusion Injury/Myocardial Reperfusion Injury/Myocardial Reperfusion Injury/*metabolism

• Source: Peptides [Peptides] 2020 Jan; Vol. 123, pp. 170200. Date of Electronic Publication: 2019 Nov 12.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 8008690 Publication Model: Print-Electronic Cited Medium: Internet

Record details

The predictive value of plasma catestatin for all-cause and cardiac deaths in chronic heart failure patients.

• Authors : Peng F; Department of Cardiology, Peking University First Hospital, No. 8, Xishiku Street, West District, Beijing, 100034, PR China.; Chu S

Subjects: Chromogranin A/Chromogranin A/Chromogranin A/*blood ; Heart Failure/Heart Failure/Heart Failure/*blood ; Peptide Fragments/Peptide Fragments/Peptide Fragments/*blood

• Source: Peptides [Peptides] 2016 Dec; Vol. 86, pp. 112-117. Date of Electronic Publication: 2016 Oct 19.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 8008690 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injury.

• Authors : Filice E; Department of Biology, Ecology and Earth Sciences, University of Calabria, 87036 Arcavacata di Rende, CS, Italy.; Pasqua T

Subjects: Cardiotonic Agents/Cardiotonic Agents/Cardiotonic Agents/*pharmacology ; Chromogranin A/Chromogranin A/Chromogranin A/*pharmacology ; Myocardial Reperfusion Injury/Myocardial Reperfusion Injury/Myocardial Reperfusion Injury/*drug therapy

• Source: Peptides [Peptides] 2015 Sep; Vol. 71, pp. 40-8. Date of Electronic Publication: 2015 Jul 04.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 8008690 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Usefulness of catestatin to predict malignant arrhythmia in patients with acute myocardial infarction.

• Authors : Pei Z; Intervention Division, Taiyuan City Centre Hospital, Taiyuan 030001, China. Electronic address: .; Ma D

Subjects: Arrhythmias, Cardiac/Arrhythmias, Cardiac/Arrhythmias, Cardiac/*blood ; Chromogranin A/Chromogranin A/Chromogranin A/*blood ; Myocardial Infarction/Myocardial Infarction/Myocardial Infarction/*blood

• Source: Peptides [Peptides] 2014 May; Vol. 55, pp. 131-5. Date of Electronic Publication: 2014 Mar 11.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 8008690 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Plasma levels and diagnostic value of catestatin in patients with heart failure.

• Authors : Liu L; Department of Cardiology, Peking University First Hospital, No. 1, Dahongluochang Street, West District, Beijing 100034, PR China.; Ding W

Subjects: Chromogranin A/Chromogranin A/Chromogranin A/*blood ; Heart Failure/Heart Failure/Heart Failure/*blood ; Heart Failure/Heart Failure/Heart Failure/*diagnosis

• Source: Peptides [Peptides] 2013 Aug; Vol. 46, pp. 20-5. Date of Electronic Publication: 2013 May 20.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 8008690 Publication Model: Print-Electronic Cited Medium: Internet

Record details

GE-25-like immunoreactivity in the rat eye.

• Authors : Lorenz K; Department of Ophthalmology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany.; Gramlich OW

Subjects: Chromogranin A/Chromogranin A/Chromogranin A/*metabolism ; Eye/Eye/Eye/*metabolism ; Peptide Fragments/Peptide Fragments/Peptide Fragments/*metabolism

• Source: Peptides [Peptides] 2012 Aug; Vol. 36 (2), pp. 286-91. Date of Electronic Publication: 2012 May 23.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 8008690 Publication Model: Print-Electronic Cited Medium: Internet

Record details